The North America coagulation analyzers market is expected to grow from US$ 1,802.76 million in 2022 to US$ 2,529.13 million by 2028. It is estimated to grow at a CAGR of 5.8% from 2022 to 2028.
In addition, the growing incidence of blood disorders is likely to increase the demand for coagulation analyzers in the coming years. For instance, as per the CDC, Hemophilia A affects 1 in 5,000 male births. Approximately 400 babies are born with hemophilia A each year. From 2012 to 2018, ~33,000 males in the US were living with hemophilia. Further, ~300,000 Canadians carry an inherited bleeding disorder gene. One in ten of these people; at least 30,000 Canadians; have symptoms severe enough to require medical care. Many of them have not been properly diagnosed. Only 10,000 people with inherited bleeding disorders are registered in the Canadian network of inherited bleeding disorder comprehensive care clinics. Also, increasing awareness program for blood disorders is likely to favor the market growth in the coming years. Hemophilia Health Education and Prevention Funded Projects is the largest program in CDC's Division of Blood Disorders. CDC has funded projects that are designed to promote health and prevent complications related to bleeding disorders. Thus, the increasing number of blood disorders, growing incidence of cardiovascular diseases, and rising government support for the prevention of blood disorders in the region are a few factors anticipated to boost the North America coagulation analyzers market growth during the forecast period.
Increasing Prevalence of Blood Disorders Drives North America Coagulation Analyzers Market Growth
A coagulation analyzer is a device that measures and evaluates the speed of clot formation or clot coagulation. It provides a fast, simple way to measure blood platelet levels and thrombolin and thromboplastin levels accurately. According to the National Organizations of Rare Disorders, hemophilia A is a common X-linked recessive disorder and the second most common inherited clotting factor deficiency after von Willebrand disease. In the US, approximately 1 in 5,000 newborn males suffer from hemophilia A. According to the National Library of Medicine (NLM), in 2020, approximately 30,000-33,000 males were affected with hemophilia in the US. According to the US Department of Health & Human Services, in 2020, ~100,000 Americans had sickle cell disease (SCD), the most commonly inherited blood disorder. Furthermore, by 2050, the number of people suffering from SCD is expected to grow by ~30%. As per the National Library of Medicine, in 2022, ~1% of all individuals (unselected population) are suffering from von Willebrand disease, i.e., 125 per 1 million. According to National Organization for Rare Disorders, in 2022, in the US, immune thrombocytopenia (ITP), an autoimmune bleeding disorder, affects approximately 66 adults per 1 million each year. Moreover, in the US, the incidence of ITP in adults is ~3.3 per 100,000/year, while the prevalence is 9.5 per 100,000. Thus, the increasing prevalence of blood disorders is driving the North America coagulation analyzers markett growth.North America Coagulation Analyzers Market Overview
In North America, the US is the largest market for coagulation analyzers. The growth of this market is primarily driven by rising developments by the market players, and increasing presence of major market players in the US. Further, the growing prevalence of atrial fibrillation is likely to increase the demand for anticoagulant reversal drugs. As per the Centers for Disease Control and Prevention (CDC), in 2019, in the US, AFib was mentioned on ~183,321 death certificates and was the primary cause of death in approximately 26,535 of those deaths. Additionally, the CDC also anticipated that by 2030, 12.1 million people in the US are likely to suffer from AFib. As per the Canadian Task Force on Preventive Health Care, in Canada, the incidence of atrial fibrillation is up to 4.5% per year, with a lifetime risk of ~25% among people older than 40 years.In addition, the growing incidence of blood disorders is likely to increase the demand for coagulation analyzers in the coming years. For instance, as per the CDC, Hemophilia A affects 1 in 5,000 male births. Approximately 400 babies are born with hemophilia A each year. From 2012 to 2018, ~33,000 males in the US were living with hemophilia. Further, ~300,000 Canadians carry an inherited bleeding disorder gene. One in ten of these people; at least 30,000 Canadians; have symptoms severe enough to require medical care. Many of them have not been properly diagnosed. Only 10,000 people with inherited bleeding disorders are registered in the Canadian network of inherited bleeding disorder comprehensive care clinics. Also, increasing awareness program for blood disorders is likely to favor the market growth in the coming years. Hemophilia Health Education and Prevention Funded Projects is the largest program in CDC's Division of Blood Disorders. CDC has funded projects that are designed to promote health and prevent complications related to bleeding disorders. Thus, the increasing number of blood disorders, growing incidence of cardiovascular diseases, and rising government support for the prevention of blood disorders in the region are a few factors anticipated to boost the North America coagulation analyzers market growth during the forecast period.
North America Coagulation Analyzers Market Revenue and Forecast to 2028 (US$ Million)
North America Coagulation Analyzers Market Segmentation
The North America coagulation analyzers market is segmented on the basis of product, test, technology, end users, and country.- Based on product, the North America coagulation analyzers market is bifurcated into clinical laboratory analyzers and point-of-care testing analyzers. The clinical laboratory analyzers segment held a larger North America coagulation analyzers market share in 2022.
- Based on test, the North America coagulation analyzers market is segmented into prothrombin time testing, fibrinogen testing, activated clotting time testing, activated partial thromboplastin time testing, D-dimer testing, platelet function tests, anti-factor XA tests, heparin and protamine dose response tests for act, and others. The prothrombin time testing segment held the largest North America coagulation analyzers market share in 2022.
- Based on technology, the North America coagulation analyzers market is segmented into optical technology, mechanical technology, electrochemical technology, and other technologies. The optical technology segment held the largest North America coagulation analyzers market share in 2022.
- Based on end users, the North America coagulation analyzers market is segmented into hospitals, clinical laboratories, point-of-care testing, and others. The clinical laboratories segment held the largest North America coagulation analyzers market share in 2022.
- Based on country, the North America coagulation analyzers market is segmented into the US, Canada, and Mexico. The US dominated the North America coagulation analyzers market share in 2022.
Table of Contents
1. Introduction1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 North America coagulation analyzer market - By Product
1.3.2 North America coagulation analyzer market - By Test
1.3.3 North America coagulation analyzer market - By Technology
1.3.4 North America coagulation analyzer market - By End Users
1.3.5 North America coagulation analyzer market - By Country
2. North America Coagulation Analyzer Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Coagulation Analyzers Market- Market Landscape
4.1 Overview
4.2 North America - PEST Analysis
4.3 Expert Opinion
5. North America Coagulation Analyzers Market- Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Prevalence of Blood Disorders
5.1.2 Rising Incidence of Cardiovascular Diseases
5.2 Market Restraints
5.2.1 High Costs and Stringent Regulations Associated with Coagulation Analyzers
5.3 Market Opportunities
5.3.1 Increasing Organic and Inorganic Strategies by Key Players
5.4 Future Trends
5.4.1 Development of Point-of-Care (POC) Coagulation Analyzers
5.5 Impact Analysis
6. Coagulation Analyzer Market -North America Analysis
6.1 North America coagulation analyzer market Revenue Forecast & Analysis
7. North America Coagulation Analyzers Market Analysis - By Product Type
7.1 Overview
7.2 North America Coagulation Analyzers Market Revenue Share, by Product Type (2021 and 2028)
7.3 Clinical Laboratory Analyzers
7.3.1 Overview
7.3.2 Clinical Laboratory Analyzers: North America Coagulation Analyzers Market - Revenue and Forecast to 2028 (US$ Million)
7.3.3 System
7.3.3.1 Overview
7.3.3.2 System: North America Coagulation Analyzers Market - Revenue and Forecast to 2028 (US$ Million)
7.3.4 Consumables
7.3.4.1 Overview
7.3.4.2 Consumables: North America Coagulation Analyzers Market - Revenue and Forecast to 2028 (US$ Million)
7.5 Point of Care Testing Analyzers
7.5.1 Overview
7.5.2 Point of Care Testing Analyzers: North America Coagulation Analyzers Market - Revenue and Forecast to 2028 (US$ Million)
8. North America Coagulation Analyzers Market Analysis - By Test
8.1 Overview
8.2 North America Coagulation Analyzers Market Revenue Share, by Test (2021 and 2028)
8.3 Prothrombin Time Testing
8.3.1 Overview
8.3.2 Prothrombin Time Testing: North America Coagulation Analyzers Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Fibrinogen Testing
8.4.1 Overview
8.4.2 Fibrinogen Testing: North America Coagulation Analyzers Market - Revenue and Forecast to 2028 (US$ Million)
8.5 Activated Clotting Time Testing
8.5.1 Overview
8.5.2 Activated Clotting Time Testing: North America Coagulation Analyzers Market - Revenue and Forecast to 2028 (US$ Million)
8.6 D-Dimer Testing
8.6.1 Overview
8.6.2 D-Dimer Testing : North America Coagulation Analyzers Market - Revenue and Forecast to 2028 (US$ Million)
8.7 Activated Partial Thromboplastin Time Testing
8.7.1 Overview
8.7.2 Activated Partial Thromboplastin Time Testing: North America Coagulation Analyzers Market - Revenue and Forecast to 2028 (US$ Million)
8.8 Platelets Function Testing
8.8.1 Overview
8.8.2 Platelets Function Testing: North America Coagulation Analyzers Market - Revenue and Forecast to 2028 (US$ Million)
8.9 Others
8.9.1 Overview
8.9.2 Others: North America Coagulation Analyzers Market - Revenue and Forecast to 2028 (US$ Million)
9. North America Coagulation Analyzers Market Analysis - By Technology
9.1 Overview
9.2 North America Coagulation Analyzers Market Revenue Share, by Technology (2021 and 2028)
9.3 Optical Technology
9.3.1 Overview
9.3.2 Optical Technology: North America Coagulation Analyzers Market - Revenue and Forecast to 2028 (US$ Million)
9.4 Mechanical Technology
9.4.1 Overview
9.4.1.1 Mechanical Technology: North America Coagulation Analyzers Market - Revenue and Forecast to 2028 (US$ Million)
9.5 Electrochemical Technology
9.5.1.1 Overview
9.5.2 Electrochemical Technology: North America Coagulation Analyzers Market - Revenue and Forecast to 2028 (US$ Million)
9.7 Others
9.7.1 Overview
9.7.2 Others: North America Coagulation Analyzers Market - Revenue and Forecast to 2028 (US$ Million)
10. North America Coagulation Analyzers Market Analysis - By End User
10.1 Overview
10.2 North America Coagulation Analyzers Market Revenue Share, by End User (2021 and 2028)
10.2.1 Clinical Laboratories
10.2.1.1 Overview
10.2.1.2 Clinical Laboratories: North America Coagulation Analyzers Market - Revenue and Forecast to 2028 (US$ Million)
10.2.2 Hospital
10.2.2.1 Overview
10.2.2.2 Hospital: North America Coagulation Analyzers Market - Revenue and Forecast to 2028 (US$ Million)
10.2.3 Others
10.2.3.1 Overview
10.2.3.2 Others: North America Coagulation Analyzers Market - Revenue and Forecast to 2028 (US$ Million)
11. North America Coagulation Analyzers Market Analysis and Forecasts To 2028 - Country Analysis
11.1 Overview
11.1.1 North America Coagulation Analyzers Market, by Country, 2021& 2028 (%)
11.1.1.1 US: North America Coagulation Analyzers Market - Revenue and Forecast to 2028 (US$ Million)
11.1.1.1.1 US: North America Coagulation Analyzers Market, by Product, 2019-2028 (US$ Million)
11.1.1.1.1.1 US: North America Coagulation Analyzers Market, by Clinical Laboratory Analyzers, 2019-2028 (US$ Million)
11.1.1.1.2 US: North America Coagulation Analyzers Market, by Test, 2019-2028 (US$ Million)
11.1.1.1.3 US: North America Coagulation Analyzers Market, by Technology, 2019-2028 (US$ Million)
11.1.1.1.4 US: North America Coagulation Analyzers Market, by End Users , 2019-2028 (US$ Million)
11.1.1.2 Canada: North America Coagulation Analyzers Market - Revenue and Forecast to 2028 (US$ Million)
11.1.1.2.1 Canada: North America Coagulation Analyzers Market, by Product, 2019-2028 (US$ Million)
11.1.1.2.1.1 Canada: North America Coagulation Analyzers Market, by Clinical Laboratory Analyzers, 2019-2028 (US$ Million)
11.1.1.2.2 Canada: North America Coagulation Analyzers Market, by Test, 2019-2028 (US$ Million)
11.1.1.2.3 Canada: North America Coagulation Analyzers Market, by Technology, 2019-2028 (US$ Million)
11.1.1.2.4 Canada: North America Coagulation Analyzers Market, by End Users, 2019-2028 (US$ Million)
11.1.1.3 Mexico: North America Coagulation Analyzers Market - Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.1 Mexico: North America Coagulation Analyzers Market, by Product, 2019-2028 (US$ Million)
11.1.1.3.1.1 Mexico: North America Coagulation Analyzers Market, by Clinical Laboratory Analyzers, 2019-2028 (US$ Million)
11.1.1.3.2 Mexico: North America Coagulation Analyzers Market, by Test, 2019-2028 (US$ Million)
11.1.1.3.3 Mexico: North America Coagulation Analyzers Market, by Technology, 2019-2028 (US$ Million)
11.1.1.3.4 Mexico: North America Coagulation Analyzers Market, by End Users, 2019-2028 (US$ Million)
12. Coagulation Analyzers Market-Industry Landscape
12.1 Overview
12.2 Growth Strategies in the Coagulation Analyzers Market
12.3 Inorganic Growth Strategies
12.3.1 Overview
12.4 Organic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 Abbott Laboratories
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Danaher Corp
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Siemens Healthcare GmbH
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Thermo Fisher Scientific Inc
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Sysmex Corporation
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Horiba Ltd.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Nihon Kohden Corp
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 F. Hoffmann-La Roche Ltd
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
14. Appendix
14.1 About the Publisher
14.2 Glossary of Terms
List of Tables
Table 1. US: North America Coagulation Analyzers Market, by Product - Revenue and Forecast to 2028 (US$ Million)
Table 2. US: North America Coagulation Analyzers Market, by Clinical Laboratory Analyzers - Revenue and Forecast to 2028 (US$ Million)
Table 3. US: North America Coagulation Analyzers Market, by Test - Revenue and Forecast to 2028 (US$ Million)
Table 4. US: North America Coagulation Analyzers Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 5. US: North America Coagulation Analyzers Market, by End Users - Revenue and Forecast to 2028 (US$ Million)
Table 6. Canada: North America Coagulation Analyzers Market, by Product - Revenue and Forecast to 2028 (US$ Million)
Table 7. Canada: North America Coagulation Analyzers Market, by Clinical Laboratory Analyzers - Revenue and Forecast to 2028 (US$ Million)
Table 8. Canada: North America Coagulation Analyzers Market, by Test - Revenue and Forecast to 2028 (US$ Million)
Table 9. Canada: North America Coagulation Analyzers Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 10. Canada: North America Coagulation Analyzers Market, by End Users - Revenue and Forecast to 2028 (US$ Million)
Table 11. Mexico: North America Coagulation Analyzers Market, by Product - Revenue and Forecast to 2028 (US$ Million)
Table 12. Mexico: North America Coagulation Analyzers Market, by Clinical Laboratory Analyzers - Revenue and Forecast to 2028 (US$ Million)
Table 13. Mexico: North America Coagulation Analyzers Market, by Test - Revenue and Forecast to 2028 (US$ Million)
Table 14. Mexico: North America Coagulation Analyzers Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 15. Mexico: North America Coagulation Analyzers Market, by End Users - Revenue and Forecast to 2028 (US$ Million)
Table 16. Recent Inorganic Growth Strategies in the Coagulation Analyzers Market
Table 17. Recent Organic Growth Strategies in the Coagulation Analyzers Market
Table 1. List of Abbreviation
List of Figures
Figure 1. North America Coagulation Analyzer Market Segmentation
Figure 2. North America Coagulation Analyzer Market Segmentation, By Country
Figure 3. North America coagulation analyzer market Overview
Figure 4. Clinical Laboratory Analyzers Held Largest Share of Type Segment in North America coagulation analyzer market
Figure 5. Canada Is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. North America: PEST Analysis
Figure 7. Experts’ Opinion
Figure 8. North America Coagulation Analyzer Market Impact Analysis of Driver and Restraints
Figure 9. North America coagulation analyzer market - Revenue Forecast and Analysis - 2020- 2028
Figure 10. North America Coagulation Analyzers Market Revenue Share, by Product Type (2021 and 2028)
Figure 11. Clinical Laboratory Analyzers: North America Coagulation Analyzers Market - Revenue and Forecast to 2028 (US$ Million)
Figure 12. System: North America Coagulation Analyzers Market - Revenue and Forecast to 2028 (US$ Million)
Figure 13. Point of Care Testing Analyzers: North America Coagulation Analyzers Market - Revenue and Forecast to 2028 (US$ Million)
Figure 14. Point of Care Testing Analyzers: North America Coagulation Analyzers Market - Revenue and Forecast to 2028 (US$ Million)
Figure 15. North America Coagulation Analyzers Market Revenue Share, by Test (2021 and 2028)
Figure 16. Prothrombin Time Testing: North America Coagulation Analyzers Market - Revenue and Forecast to 2028 (US$ Million)
Figure 17. Fibrinogen Testing: North America Coagulation Analyzers Market - Revenue and Forecast to 2028 (US$ Million)
Figure 18. Activated Clotting Time Testing: North America Coagulation Analyzers Market - Revenue and Forecast to 2028 (US$ Million)
Figure 19. D-Dimer Testing : North America Coagulation Analyzers Market - Revenue and Forecast to 2028 (US$ Million)
Figure 20. Activated Partial Thromboplastin Time Testing: North America Coagulation Analyzers Market - Revenue and Forecast to 2028 (US$ Million)
Figure 21. Platelets Function Testing: North America Coagulation Analyzers Market - Revenue and Forecast to 2028 (US$ Million)
Figure 22. Others: North America Coagulation Analyzers Market - Revenue and Forecast to 2028 (US$ Million)
Figure 23. North America Coagulation Analyzers Market Revenue Share, by Technology (2021 and 2028)
Figure 24. Optical Technology: North America Coagulation Analyzers Market - Revenue and Forecast to 2028 (US$ Million)
Figure 25. Mechanical Technology: North America Coagulation Analyzers Market - Revenue and Forecast to 2028 (US$ Million)
Figure 26. Electrochemical Technology: North America Coagulation Analyzers Market - Revenue and Forecast to 2028 (US$ Million)
Figure 27. Others: North America Coagulation Analyzers Market - Revenue and Forecast to 2028 (US$ Million)
Figure 28. North America Coagulation Analyzers Market Revenue Share, by End User (2021 and 2028)
Figure 29. Clinical Laboratories: North America Coagulation Analyzers Market - Revenue and Forecast to 2028 (US$ Million)
Figure 30. Hospital: North America Coagulation Analyzers Market - Revenue and Forecast to 2028 (US$ Million)
Figure 31. Others: North America Coagulation Analyzers Market - Revenue and Forecast to 2028 (US$ Million)
Figure 32. North America Coagulation Analyzers Market, by Key Country - Revenue (2021) (US$ Million)
Figure 33. North America Coagulation Analyzers Market, by Country, 2021& 2028 (%)
Figure 34. US: North America Coagulation Analyzers Market - Revenue and Forecast to 2028 (US$ Million)
Figure 35. Canada: North America Coagulation Analyzers Market - Revenue and Forecast to 2028 (US$ Million)
Figure 36. Mexico: North America Coagulation Analyzers Market - Revenue and Forecast to 2028 (US$ Million)
Figure 37. Growth Strategies in the Coagulation Analyzers Market
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Danaher Corp
- F. Hoffmann-La Roche Ltd
- Horiba Ltd.
- Nihon Kohden Corp
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
- Siemens Healthcare GmbH
- Sysmex Corporation
- Thermo Fisher Scientific Inc
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 151 |
| Published | February 2023 |
| Forecast Period | 2022 - 2028 |
| Estimated Market Value ( USD | $ 1802.76 Million |
| Forecasted Market Value ( USD | $ 2529.13 Million |
| Compound Annual Growth Rate | 5.8% |
| Regions Covered | North America |
